Drug intelligence / Profile preview

Jiedu Huayu

Development stage
Phase 3
Administration
Oral
01

Overview

Jiedu Huayu is a Traditional Chinese Medicine (TCM) formula, often prepared as granules, primarily utilized for the treatment of liver injury and liver failure, including acute liver failure (ALF) and chronic liver failure (CLF). Its therapeutic efficacy is attributed to its ability to modulate the immune system and inflammatory responses. Specifically, Jiedu Huayu has been shown to inhibit T-cell mediated immunity by reducing the expression of cytotoxic T lymphocyte (CTL) related factors such as perforin, granule B, and PD-1. It also decreases hepatic apoptotic factors like OX62, FAS, and TNFR1, thereby mitigating hepatocyte apoptosis. Furthermore, it influences the balance of various cytokines, increasing anti-inflammatory cytokines like IL-10 and IL-13, while decreasing pro-inflammatory cytokines such as IFN-γ, IL-6, IL-1β, and TNF-α. The drug also regulates the NF-κB signaling pathway and modulates IL-2 and TLR4 expression, contributing to its anti-inflammatory and hepatoprotective effects, and promoting hepatocyte regeneration.

Other names
Jiedu Huayu granulesJDHY
02

Targets

MAPK3 (Mitogen-activated protein kinase 1)IL-6 (Interleukin 6)PPARA (Peroxisome proliferator-activated receptor alpha)NF-κBJNK (Mitogen-activated protein kinase kinase kinase family)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)RK (Ribokinase)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on Jiedu Huayu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiedu Huayu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call